Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Content analysis
?Positive | ||
Negative | ||
Uncertain | ||
Constraining | ||
Legalese | ||
Litigous | ||
Readability |
H.S. junior Avg
|
New words:
advanz, alert, approx, blinded, Carolina, child, conjunction, decentralize, delisted, delisting, DMC, England, EUR, FDORA, govorestat, holdback, hospital, indexation, invoiced, Kingdom, Korea, majeure, Mercury, negligence, notifying, older, perpetuity, pharma, pre, recoup, regain, regained, reset, specialty, speed, Switzerland, trend, unblinded, USD, young
Removed:
alpha, avoiding, catalytic, certified, characterize, comprising, constitutively, Cooperation, delta, diarrhea, explanation, gamma, hematological, hepatic, House, leukemia, lymphoblastic, lymphoma, moderate, Nov, PCT, phosphatidylinositol, plagued, restrictive, signaling, solid, subunit, threatening, Treaty, tumor, Utilizing
Filing tables
Filing exhibits
Related press release
APLT similar filings
Filing view
External links
Exhibit 23.1
Consent of Independent Registered Public Accounting Firm
We consent to the incorporation by reference in the following Registration Statements:
● | Registration Statement (Form S-8 No. 333-231618) of Applied Therapeutics, Inc., |
● | Registration Statement (Form S-8 No. 333-255018) of Applied Therapeutics, Inc, and |
● | Registration Statement (Form S-3 No. 333-238948) of Applied Therapeutics, Inc. |
of our report dated March 23, 2023, with respect to the financial statements of Applied Therapeutics, Inc. included in this Annual Report (Form 10-K) of Applied Therapeutics for the year ended December 31, 2022.
|
|
8 |
/s/ Ernst & Young LLP |
New York, New York |
March 23, 2023 |
|